KGLDF yields 476.19% · PFE yields 6.13%● Live data
📍 KGLDF pulled ahead of the other in Year 1
Combined, KGLDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KGLDF + PFE for your $10,000?
King Global Ventures Inc., a junior prospecting and natural-resource company, engages in the acquisition and exploration of mineral properties. The company focuses on gold exploration in Newfoundland. It holds a 100% interest in the York Gold project comprising 77 claims situated in northeastern Quebec; the Boulder Gold property that consists of four contiguous claim blocks of 100 hectares located in Central Newfoundland; and the Golden Nugget property that consists of a 10-kilometer-long contiguous land package of 1850 hectares located in the north of the Davidsville group. The company also holds a 100% interest in the Miss Pickle Island property that consists of 950 hectares located in the Dunnage Coaker Corridor; and the Chapel Island property comprises 54 mining claims situated in northeast-central Newfoundland. The company was formerly known as Rosita Mining Corporation and changed its name to King Global Ventures Inc. in September 2019. King Global Ventures Inc. is headquartered in Toronto, Canada.
Full KGLDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.